Ga omhoog…

Het aantal gebruikers van diabetesmiddelen, 2003 - 2019

  2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
ATC-code  
A10AB01 Insuline (humaan) 40.541 35.740 30.776 26.623 20.721 16.656 13.752 11.995 10.339 7.967 3.440 2.962 2.641 2.439 2.213 2.010 1.769
A10AB04 Insuline lispro 17.741 17.827 17.664 18.438 17.943 17.780 17.339 17.244 17.103 16.758 16.038 15.731 16.307 16.132 16.023 15.475 14.829
A10AB05 Insuline aspart 35.493 49.049 60.323 71.987 82.262 91.315 97.960 105.184 113.285 124.935 129.282 132.499 137.250 138.679 142.362 143.356 144.154
A10AB06 Insuline glulisine . . 312 1.759 3.392 6.104 7.703 9.484 10.237 9.388 10.681 11.766 12.447 12.655 12.543 12.185 11.428
A10AC01 Insuline (humaan) 89.178 76.479 58.516 46.666 41.284 37.290 33.225 30.840 28.484 26.718 26.205 27.766 28.995 28.661 28.071 27.165 27.870
A10AD01 Insuline (humaan) 87.793 77.900 67.380 55.277 41.361 31.141 7.492 4.849 3.792 3.306 2.357 2.118 2.020 1.825 1.652 1.425 1.263
A10AD04 Insuline lispro 5.300 4.931 4.379 3.541 3.243 3.188 2.932 2.746 2.553 2.367 2.223 2.049 1.898 1.710 1.623 1.428 1.281
A10AD05 Insuline aspart 18.446 28.328 34.367 38.591 50.241 70.862 73.908 72.470 67.558 64.630 60.753 57.083 53.739 49.169 44.532 38.389 33.486
A10AD06 Insuline degludec met insuline aspart . . . . . . . . . . . . . 64 2.525 5.167 6.218
A10AE04 Insuline glargine 13.410 37.190 50.302 63.958 71.979 82.199 88.699 96.523 102.070 108.631 115.514 120.556 127.590 129.713 129.943 127.051 125.295
A10AE05 Insuline detemir . 8.307 20.268 25.435 31.666 37.383 42.428 45.659 47.733 50.145 50.370 49.769 48.726 43.254 37.634 32.494 28.638
A10AE06 Insuline degludec . . . . . . . . . . . 232 4.245 17.870 29.587 37.800 43.535
A10AE54 Insuline glargine met lixisenatide . . . . . . . . . . . . . . 159 419 587
A10AE56 Insuline degludec met liraglutide . . . . . . . . . . . . . . 1.911 2.820 2.760
A10AF01 Insuline (humaan) . . . . 10 4 1 . . . . . . . . . 6
A10BA02 Metformine 293.065 347.376 384.798 425.584 455.538 494.789 521.883 565.535 586.525 607.675 619.952 625.291 637.090 635.425 645.787 651.904 655.218
A10BB01 Glibenclamide 42.419 35.992 29.295 25.226 20.410 16.881 14.080 11.797 9.530 8.184 6.853 5.212 4.005 3.134 2.608 2.115 1.682
A10BB03 Tolbutamide 92.738 89.645 85.333 81.161 77.506 78.314 79.790 83.996 86.999 91.027 89.358 76.321 65.453 56.017 48.805 41.830 35.572
A10BB09 Gliclazide 76.199 75.398 72.254 68.979 65.949 66.026 62.000 61.920 60.508 60.252 74.936 115.499 147.800 171.811 194.525 213.946 231.941
A10BB12 Glimepiride 113.594 126.304 130.588 132.063 131.917 134.972 130.661 132.027 129.928 126.889 119.528 101.846 86.558 72.627 62.816 53.929 46.156
A10BD02 Metformine met sulfonylureumderivaten 2.968 3.310 2.820 2.691 2.238 1.748 1.425 1.281 1.098 921 566 480 425 376 321 254 228
A10BD05 Metformine met pioglitazon . . . . 43 222 262 486 483 385 302 251 195 176 153 129 98
A10BD07 Metformine met sitagliptine . . . . . 439 1.367 3.068 4.576 5.942 6.277 6.014 5.684 5.457 5.463 5.550 5.665
A10BD08 Metformine met vildagliptine . . . . . 382 1.614 3.124 3.963 4.739 5.054 4.944 4.625 4.354 4.276 4.188 4.156
A10BD10 Metformine met saxagliptine . . . . . . . . . . 33 55 47 50 46 40 9
A10BD11 Metformine met linagliptine . . . . . . . . . 7 73 140 171 187 192 217 269
A10BD15 Metformine met dapagliflozine . . . . . . . . . . . 42 131 206 235 275 312
A10BD16 Metformine met canagliflozine . . . . . . . . . . . . 2 5 3 7 2
A10BD20 Metformine met empagliflozine . . . . . . . . . . . . 2 70 253 360 386
A10BF01 Acarbose 6.695 5.471 4.420 3.288 2.634 2.061 1.599 1.297 1.139 984 1.101 1.469 1.406 1.425 1.454 1.401 1.234
A10BG03 Pioglitazon 9.056 14.391 17.845 24.284 24.733 20.282 19.361 21.687 19.342 14.932 11.411 8.785 6.976 5.636 4.704 3.873 3.254
A10BH01 Sitagliptine . . . . 1.290 5.371 7.469 12.826 17.590 23.291 23.606 22.114 21.445 21.106 21.740 24.452 29.420
A10BH02 Vildagliptine . . . . . 977 3.230 5.267 6.045 7.497 7.749 7.116 6.593 6.048 5.820 5.625 5.601
A10BH03 Saxagliptine . . . . . . . 1.216 2.441 2.897 2.609 2.163 1.797 1.431 1.280 1.135 1.065
A10BH05 Linagliptine . . . . . . . . . 2.537 4.495 5.099 5.582 6.016 6.530 7.163 8.588
A10BJ01 Exenatide . . . . . . 842 1.269 1.314 1.910 1.707 1.518 1.354 1.168 980 870 745
A10BJ02 Liraglutide . . . . . . . 3.878 7.712 10.174 11.055 10.821 10.409 9.592 10.124 11.536 11.718
A10BJ03 Lixisenatide . . . . . . . . . . . 31 58 44 89 145 149
A10BJ05 Dulaglutide . . . . . . . . . . . . 266 683 1.712 2.509 3.358
A10BJ06 Semaglutide . . . . . . . . . . . . . . . 1.264 12.096
A10BK01 Dapagliflozine . . . . . . . . . . . 1.435 3.010 4.784 6.742 8.095 7.756
A10BK02 Canagliflozine . . . . . . . . . . . 95 211 216 253 495 899
A10BK03 Empagliflozine . . . . . . . . . . . 1 290 1.672 4.335 6.820 8.350
A10BK04 Ertugliflozine . . . . . . . . . . . . . . . . 17
A10BX02 Repaglinide 814 682 638 766 888 858 832 772 764 756 693 647 599 599 632 697 701
A10BX09 Overige bloedglucoseverlagende middelen excl. insulines . . . . . . . . . . 458 1.095 75 25 4 . .
A10BX11 Overige bloedglucoseverlagende middelen excl. insulines . . . . . . . . . . . 3 23 18 17 14 .
Totaal * 551.402 591.420 614.086 646.762 656.902 691.184 706.906 745.490 765.424 785.294 795.874 799.530 811.423 807.486 819.301 821.769 826.744

* Omdat één verzekerde gebruik kan maken van meerdere geneesmiddelen met verschillende ATC-codes,

wijkt het totaal aantal gebruikers af van de som van de afzonderlijke categorieën.

Bron: GIP / Zorginstituut Nederland
Geactualiseerd op: 04-12-2020